For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.
Your partner in science for end-to-end CRDMO solutions
The Jubilant Biosys Computational Chemistry team excels in drug discovery design efforts in collaboration with the medicinal chemistry, biology and DMPK teams, by conducting molecular modeling studies – ligand-based drug design approaches (LBDD, pharmacophore and QSAR modeling), protein structure-based drug design (SBDD, homology modeling, docking and scoring), fragment-based drug design, chemoinformatic analysis and de novo design.
The team providing these computational chemistry services extensively utilizes in-house expertise in software development, curation and structural biology for driving molecular design.
Our team of computational chemists empowers drug discovery scientists to deploy ready-to-use models and make faster and wiser decisions.